Yannis Dionyssiotis

Prof. Dr. Yannis Dionyssiotis

Senior Consultant PM & R, 1st Physical Medicine & Rehabilitation Department, National Rehabilitation Center EKA, Athens, Greece
orcid
Head 2nd Physical Medicine and Rehabilitation Department, Na...

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2012 in International Journal of General Medicine
Verified
Journal Article
Open access
PDF file
Yannis DionyssiotisYannis Dionyssiotis
Yannis Dionyssiotis
Falls are a serious problem facing the elderly. The prevention of falls that contribute to disability, mainly in elderly people, is an important issue. Ensuring the greatest possible functionality for elderly people is an important element in the prevention of disability. This paper analyzes the importance of falls, risk factors for falls, and interventions to prevent falls. Recent publications as well as research regarding the prevention and rehabilitation for falls are reviewed.

13 February 2023 in Journal of Cachexia, Sarcopenia and Muscle
Verified
Journal Article
Open access
KPKonstantinos Prokopidis
Konstantinos Prokopidis
PGPanagiotis Giannos
Panagiotis Giannos
JRJean Yves Reginster
Jean Yves Reginster
OBOlivier Bruyere
Olivier Bruyere
MPMirko Petrovic
Mirko Petrovic
S(Special interest group in Systematic Reviews and Meta‐analyses and the Task Force on Pharmaceutical Strategy of the European Geriatric Medicine Society (EuGMS)
Special interest group in Systematic Reviews and Meta‐analyses and the Task Force on Pharmaceutical Strategy of the European Geriatric Medicine Society (EuGMS)
Polypharmacy in older adults is associated with multiple negative consequences that may affect muscular function, independently from the presence of medical conditions. The aim of this systematic review and meta‐analysis was to investigate the association of sarcopenia with polypharmacy and higher number of medications. A systematic literature search of observational studies using PubMed, Web of Science, Scopus and Cochrane Library databases was conducted from inception until June 2022. To determine if sarcopenia is associated with a higher risk of polypharmacy and increased number of medications, a meta‐analysis using a random‐effects model was used to calculate the pooled effects (CRD42022337539). Twenty‐nine studies were included in the systematic review and meta‐analysis. Sarcopenia was associated with a higher prevalence of polypharmacy (odds ratio [OR]: 1.65, 95% confidence interval [CI] [1.23, 2.20], I2 = 84%, P < 0.01) and higher number of medications (mean difference: 1.39, 95% CI [0.59, 2.19], I2 = 95%, P < 0.01) compared with individuals without sarcopenia. Using meta‐regression, a high variance was observed due to different populations (i.e., community‐dwelling, nursing home residents, inpatients, outpatients) for both outcomes of polypharmacy (r = −0.338, SE = 0.1669, 95% CI [−0.67, −0.01], z = −2.03, P = 0.04) and number of medications (r = 0.589, SE = 0.2615, 95% CI [0.08, 1.10], z = 2.25, P = 0.02). This systematic review and meta‐analysis reported a significantly increased risk of polypharmacy and higher number of medications in people with sarcopenia compared with individuals without this condition. Future research should clarify whether the specificity and number of medications is a direct contributor in accelerating the progression of muscle wasting and dysfunction contributing to sarcopenia in older adults.

1 February 2023 in Journal of Physical Activity and Health
Verified
Journal Article
Open access
PDF file
ARAndrea Ramirez
Andrea Ramirez
PHPedro C. Hallal
Pedro C. Hallal
JGJuliana Mejía Grueso
Juliana Mejía Grueso
ZPZeljko Pedisic
Zeljko Pedisic
DSDeborah Salvo
Deborah Salvo
MPMichael Pratt
Michael Pratt
Background: Physical activity (PA) surveillance, policy, and research efforts need to be periodically appraised to gain insight into national and global capacities for PA promotion. The aim of this paper was to assess the status and trends in PA surveillance, policy, and research in 164 countries. Methods: We used data from the Global Observatory for Physical Activity (GoPA!) 2015 and 2020 surveys. Comprehensive searches were performed for each country to determine the level of development of their PA surveillance, policy, and research, and the findings were verified by the GoPA! Country Contacts. Trends were analyzed based on the data available for both survey years. Results: The global 5-year progress in all 3 indicators was modest, with most countries either improving or staying at the same level. PA surveillance, policy, and research improved or remained at a high level in 48.1%, 40.6%, and 42.1% of the countries, respectively. PA surveillance, policy, and research scores decreased or remained at a low level in 8.3%, 15.8%, and 28.6% of the countries, respectively. The highest capacity for PA promotion was found in Europe, the lowest in Africa and low- and lower-middle-income countries. Although a large percentage of the world’s population benefit from at least some PA policy, surveillance, and research efforts in their countries, 49.6 million people are without PA surveillance, 629.4 million people are without PA policy, and 108.7 million live in countries without any PA research output. A total of 6.3 billion people or 88.2% of the world’s population live in countries where PA promotion capacity should be significantly improved. Conclusion: Despite PA is essential for health, there are large inequalities between countries and world regions in their capacity to promote PA. Coordinated efforts are needed to reduce the inequalities and improve the global capacity for PA promotion.
1

10 February 2017 in Brain Sciences
Verified
Journal Article
Open access
PDF file
FBFrancesco Barban
Francesco Barban
RARoberta Annicchiarico
Roberta Annicchiarico
MMMatteo Melideo
Matteo Melideo
AFAlessia Federici
Alessia Federici
MLMaria Giovanna Lombardi
Maria Giovanna Lombardi
CCCarlo Caltagirone
Carlo Caltagirone
Background. Falling is a major clinical problem in elderly people, demanding effective solutions. At present, the only effective intervention is motor training of balance and strength. Executive function-based training (EFt) might be effective at preventing falls according to evidence showing a relationship between executive functions and gait abnormalities. The aim was to assess the effectiveness of a motor and a cognitive treatment developed within the EU co-funded project I-DONT-FALL. Methods. In a sample of 481 elderly people at risk of falls recruited in this multicenter randomised controlled trial, the effectiveness of a motor treatment (pure motor or mixed with EFt) of 24 one-hour sessions delivered through an i-Walker with a non-motor treatment (pure EFt or control condition) was evaluated. Similarly, a 24 one-hour session cognitive treatment (pure EFt or mixed with motor training), delivered through a touch-screen computer was compared with a non-cognitive treatment (pure motor or control condition). Results. Motor treatment, particularly when mixed with EFt, reduced significantly fear of falling (F(1,478) = 6.786, p = 0.009) although to a limited extent (ES −0.25) restricted to the period after intervention. Conclusions. This study suggests the effectiveness of motor treatment empowered by EFt in reducing fear of falling.

1 December 2015 in Prosthetics and Orthotics International
Verified
Journal Article
Closed access
Yannis DionyssiotisYannis Dionyssiotis
Yannis Dionyssiotis
GTGeorgios Trovas
Georgios Trovas
STSofia Thoma
Sofia Thoma
GLGeorge Lyritis
George Lyritis
NPNikolaos Papaioannou
Nikolaos Papaioannou
There are not many clinical trials investigating the efficiency and compliance of using spinal orthoses in the management of osteoporosis. The purpose of this study was to investigate the effect of long-term use and the compliance of spinal orthoses in postmenopausal women with vertebral fractures. Clinical trial of spinal orthoses in postmenopausal women. Women were separated into groups wearing different types of orthoses (Spinomed, Osteomed, Spinomed active, and Spine-X). Isometric maximum strength of trunk muscles (F/Wabdominals–extensors) was calculated and back pain was assessed in all women. In addition, women completed a compliance questionnaire about the use of the orthoses. Spinomed decreased pain (p = 0.001) and increased trunk muscle strength (F/Wabdominals, p = 0.005 and F/Wextensors, p = 0.003, respectively). The compliance of wearing an orthosis for 6 months was 66%. The results suggest that orthoses could be an effective intervention for back pain and muscle strengthening in osteoporotic women. In women with established osteoporosis, wearing Spinomed orthosis for at least 2 h/day for 6 months decreased back pain significantly and increased personal isometric trunk muscle strength. All spinal orthoses could be valuable instruments to help all requested rehabilitation programs like spine muscles’ strengthening and postural correct behavior, but only when used properly.

1 July 2004 in Journal of Neurology, Neurosurgery & Psychiatry
Verified
Journal Article
Closed access
PDF file
Yannis DionyssiotisYannis Dionyssiotis
Yannis Dionyssiotis
YZY Zoukos
Y Zoukos
TTT Thomaides
T Thomaides